Brief: Calliditas Announces Filing With UK MHRA For Kinpeygo In IgA Nephropathy

Calliditas Therapeutics AB

03/10/2023 14:08

Oct 3 (Reuters) - Calliditas Therapeutics AB  CALTX.ST :
    * CALLIDITAS ANNOUNCES FILING WITH UK MHRA FOR KINPEYGO IN
IGA
NEPHROPATHY
    * ITS PARTNER STADA SUBMITTED A REQUEST TO MEDICINES AND
HEALTHCARE PRODUCTS REGULATORY AGENCY (MHRA) OF UK TO CONVERT
CONDITIONAL MARKETING AUTHORIZATION FOR KINPEYGO TO STANDARD, OR
"FULL", MARKETING AUTHORIZATION

Source text for Eikon:  ID:nWkr8jLsW9 
Further company coverage:  CALTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))